Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

currently with Boston Pharmaceuticals and Pfizer, which also involve 4-1BB bispecific proteins. Pfizer is developing SGN-BB228, a CD228/4-1BB candidate it inherited as part of its takeover of ...

Analysts at Jefferies said that Indian pharmaceutical businesses, who depend heavily on the United States for their income, ...

Scientific researchers on Wednesday sued to secure reinstatement of National Institutes of Health grants that funded research ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

Vertex Pharmaceuticals Incorporated (NASDAQ ... and other conditions. The Boston, Massachusetts-based company collaborates with CRISPR Therapeutics, Moderna, and Entrada Therapeutics, and sells ...

It looks like it’s back to the drawing board for Gov. Maura Healey in her bid to extract more revenue to support her spending ...

Michael “Melch” Melchione, 58, of Middletown, RI, passed away on March 31, 2025, in Middletown. Michael was born in South ...

Means argued that the substantial cuts Kennedy has made to Health and Human Services, the National Institutes of Health, the ...

But if a lawmaker happens to lead a nonprofit — as is the case for a handful of lawmakers on Beacon Hill — lobbyists and ...

Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.